Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2003-10-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.2235595100PMID 14569010PMCID PMC240708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 and apoptosis.

  2007cited by this paper
• Culture of animal cells : a manual of basic technique

  2005cited by this paper
• Somatic stem cells and the kinetics of mutagenesis and carcinogenesis

  2002cited by this paper
• A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.

  2002cited by this paper
• Proliferation is necessary for both repair and mutation in transgenic mouse cells.

  2000cited by this paper
• Requirement of wild‐type p53 protein for maintenance of chromosomal integrity

  2000cited by this paper
• Cancer: p53 sends nucleotides to repair DNA

  2000cited by this paper
• Regulation of p53 in response to DNA damage

  1999cited by this paper
• Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells

  1997cited by this paper
• On the origin of spontaneous somatic mutations and sectored plaques detected in transgenic mice.

  1997cited by this paper
• Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells.

  1997cited by this paper
• Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells

  1997cited by this paper
• System issues: Why do stem cells exist?

  1996cited by this paper
• Inhibition by quercetin and luteolin of chromosomal alterations induced by salted, deep-fried fish and mutton in rats.

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques.

  1996cited by this paper
• p53 deficiency does not affect the accumulation of point mutations in a transgene target.

  1995cited by this paper
• p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.

  1995cited by this paper
• Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses.

  1994cited by this paper
• Clastogenicity of lanthanides--induction of micronuclei in root tips of Vicia faba.

  1994cited by this paper
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

  1994cited by this paper
• The use of shuttle vectors for mutation analysis in transgenic mice and rats.

  1994cited by this paper
• Response of the MutaTMmouse lacZ/galE− transgenic mutation assay to DMN: comparisons with the corresponding Big BlueTM (lacI) responses

  1994cited by this paper
• Clinical implications of the p53 tumor-suppressor gene.

  1993cited by this paper
• Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor.

  1993cited by this paper
• Double-strand breaks in plasmid DNA and the induction of deletions.

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

  1991cited by this paper
• Cancer. A deadly inheritance.

  1990cited by this paper
• A deadly inheritance

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Culture of Animal Cells: A Manual of Basic Technique

  1984cited by this paper
• Mutation selection and the natural history of cancer

  1975cited by this paper

• Therapeutic response in human cancers : the dual role of STAT signalling

  2016cites this paper
• The rate of spontaneous mutations in human myeloid cells.

  2013cites this paper
• Synthesis of Azulenylsilane Nitrones as Diagnostic Tools for Superoxide Detection

  2011cites this paper
• Mutational Heterogeneity in Human Cancers : Origin and Consequences

  2010cites this paper
• Mutational heterogeneity in human cancers: origin and consequences.

  2010cites this paper
• Analysis of Nonlinear Relations between Expression Profiles by the Principal Curves of Oriented-Points Approach

  2008cites this paper
• Highly Conserved Regimes of Neighbor-Base-Dependent Mutation Generated the Background Primary-Structural Heterogeneities along Vertebrate Chromosomes

  2008cites this paper
• Unifying concept of DNA repair: The polymerase scanning hypothesis

  2005cites this paper
• Mutator phenotype in cancer: Timing and perspectives

  2005cites this paper
• Quantification of random genomic mutations

  2005cites this paper
• Proteomic studies of pseudomonas putida KT2440 in carcinogenicity screening via 2-dimensional gel electrophoresis

  2005cites this paper